Valuation: IXICO plc

Market Cap 1.64Cr 2.22Cr 1.91Cr 1.8Cr 3.07Cr 211.96Cr 3.12Cr 21Cr 8.25Cr 106.19Cr 8.32Cr 8.14Cr 353.25Cr P/E 2026 *
-5.36x
P/E 2027 * -5.77x
Enterprise Value 61.54L 83.42L 72.01L 67.56L 1.16Cr 80Cr 1.17Cr 7.92Cr 3.1Cr 40Cr 3.13Cr 3.06Cr 132.92Cr EV / Sales 2026 *
0.77x
EV / Sales 2027 * 1.14x
Free-Float
89.22%
Yield 2026 *
-
Yield 2027 * -
1 week-6.25%
Current month-6.25%
1 month-11.76%
3 months+11.11%
6 months-15.49%
Current year-36.17%
1 week 7
Extreme 7
8
1 month 7
Extreme 7
9
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
15
3 years 6.26
Extreme 6.26
21
5 years 6.26
Extreme 6.26
92
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 19/08/2024
Director of Finance/CFO 50 21/08/2019
Chief Tech/Sci/R&D Officer - 01/06/2025
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 21/08/2019
Director/Board Member 60 21/01/2022
Date Insider Type Main position Quantity % Market Cap.
15/07/26 Buy

Chairman

50,006 0.0228%
13/06/25 Free 3,50,000 0.3777%
13/06/25 Free 3,50,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-6.25%-38.78%-63.05% 2.22Cr
+0.68%-2.28%+2.16%+19.70% 4.84TCr
+4.07%+2.43%+483.70%+623.80% 4.37TCr
+4.33%+0.98%+12.80%+88.53% 3.95TCr
+1.94%-0.31%+26.24%+12.62% 3.9TCr
-0.50%0.00%+20.60%+60.49% 3.26TCr
-0.44%-3.22% - - 1.63TCr
+3.22%-0.88%+30.42%+135.47% 1.61TCr
-0.62%-0.06%+3.46%+27.74% 1.42TCr
+2.35%+3.48%+82.95%+43.41% 1.34TCr
Average +1.50%-0.61%+69.28%+105.41% 2.63TCr
Weighted average by Cap. +1.93%+0.03%+101.57%+151.15%

Financials

2026 *2027 *
Net sales 80L 1.08Cr 93.62L 87.83L 1.5Cr 103.69Cr 1.53Cr 10Cr 4.03Cr 52Cr 4.07Cr 3.98Cr 172.81Cr 90L 1.22Cr 1.05Cr 98.81L 1.69Cr 116.65Cr 1.72Cr 12Cr 4.54Cr 58Cr 4.58Cr 4.48Cr 194.41Cr
Net income -21.43L -29.05L -25.08L -23.53L -40.3L -28Cr -40.85L -2.76Cr -1.08Cr -14Cr -1.09Cr -1.07Cr -46Cr -28.01L -37.97L -32.78L -30.75L -52.67L -36Cr -53.4L -3.61Cr -1.41Cr -18Cr -1.43Cr -1.39Cr -61Cr
Net Debt -1.02Cr -1.38Cr -1.19Cr -1.12Cr -1.92Cr -132.21Cr -1.94Cr -13Cr -5.14Cr -66Cr -5.19Cr -5.08Cr -220.33Cr -61L -82.69L -71.39L -66.97L -1.15Cr -79Cr -1.16Cr -7.85Cr -3.08Cr -40Cr -3.1Cr -3.04Cr -131.76Cr
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
17/26/17 GBX 7.500 0.00% 9,640
14/26/14 GBX 7.500 0.00% 0
13/26/13 GBX 7.500 0.00% 10,096
12/26/12 GBX 7.500 +3.45% 258
11/26/11 GBX 7.250 -9.38% 1,34,025
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0750GBP
Average target price
0.2600GBP
Spread / Average Target
+246.67%

Annual profits - Rate of surprise